YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (1558.HK)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap6.15B
EV6.15B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
64.2
100.9
137.1
233.3
365.7
906.6
342.0
133.1
545.5
771.3
Revenue % Chg.
—
57.2%
35.9%
70.1%
56.8%
147.9%
-62.3%
-61.1%
309.8%
157.6%
Cost of Revenue
17.5
26.0
31.2
40.8
58.1
134.3
51.2
62.6
130.9
115.2
Gross Profit
46.8
74.9
105.9
192.4
307.6
772.3
290.8
70.5
414.5
656.1
Gross Profit Margin
72.8%
74.3%
77.2%
82.5%
84.1%
85.2%
85.0%
52.9%
76.0%
85.1%
R&D Expenses
—
—
—
—
—
—
—
16.0
18.9
—
Selling, General, & Admin Expenses
24.8
28.8
45.7
82.3
151.2
417.9
227.9
128.2
226.5
351.2
Other Expenses
-4.9
-2.0
-1.1
-1.0
-1.5
-1.3
-1.6
-9.5
-2.4
-1.4
Operating Income
29.9
49.5
67.0
109.6
160.8
360.3
130.6
-64.2
126.4
313.2
Operating Income Margin
46.6%
49.0%
48.9%
47.0%
44.0%
39.7%
38.2%
-48.2%
23.2%
40.6%
Total Other Income/Expenses Net
-6.2
-3.6
-1.1
-0.6
-0.2
-29.8
16.5
-33.0
-120.6
-25.2
Income Before Tax
23.8
45.8
66.0
109.0
160.6
330.5
147.2
-97.2
5.7
288.0
Income Before Tax Margin
37.0%
45.4%
48.1%
46.7%
43.9%
36.5%
43.0%
-73.0%
1.1%
37.3%
Income Tax Expense
4.0
7.1
10.6
17.7
29.3
52.7
25.2
-11.6
-1.4
46.9
Net Income
19.7
38.7
55.4
94.3
137.3
279.5
122.3
-85.6
7.2
241.2
Net Income Margin
30.7%
38.4%
40.4%
40.4%
37.5%
30.8%
35.8%
-64.3%
1.3%
31.3%
Weighted Avg. Shares Out
901.3
671.1
901.6
903.8
904.0
889.2
881.5
880.0
—
899.8
EPS
0.0
0.1
0.1
0.1
0.2
0.3
0.1
-0.1
—
0.3
EPS % Chg.
—
166.7%
5.0%
71.4%
45.8%
105.7%
-56.0%
—
—
119.0%
Weighted Avg. Shares Out Dil
901.3
671.1
901.6
903.8
904.0
1,009.7
1,105.8
880.0
—
990.2
EPS Diluted
0.0
0.1
0.1
0.1
0.2
0.3
0.1
-0.1
—
0.2
Interest Income
3.1
0.3
1.2
2.1
2.1
5.2
3.6
1.7
1.0
—
Interest Expense
6.2
3.6
1.1
0.6
0.2
29.8
35.6
35.5
41.0
22.4
EBIT
20.7
42.5
66.1
110.5
162.5
306.0
115.2
-131.0
-34.3
265.6
EBIT Margin
32.2%
42.1%
48.2%
47.4%
44.4%
33.7%
33.7%
-98.5%
-6.3%
34.4%
Depreciation & Amortization
4.7
3.7
4.0
6.4
8.9
12.6
17.9
46.7
55.0
11.6
EBITDA
25.3
46.3
70.1
116.9
171.4
318.5
133.1
-84.4
20.7
277.3
EBITDA Margin
39.5%
45.9%
51.1%
50.1%
46.9%
35.1%
38.9%
-63.4%
3.8%
35.9%